MA43103B1 - Peptides macrocycliques contre acetinobacter baumannii - Google Patents
Peptides macrocycliques contre acetinobacter baumanniiInfo
- Publication number
- MA43103B1 MA43103B1 MA43103A MA43103A MA43103B1 MA 43103 B1 MA43103 B1 MA 43103B1 MA 43103 A MA43103 A MA 43103A MA 43103 A MA43103 A MA 43103A MA 43103 B1 MA43103 B1 MA 43103B1
- Authority
- MA
- Morocco
- Prior art keywords
- macrocyclic peptides
- peptides against
- baumannii
- acetinobacter
- formula
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000588626 Acinetobacter baumannii Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés représentés par la formule (i) dans laquelle , x 1 à x8 et r1 à r8 ont la signification indiquée dans la description, ainsi que des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne également la fabrication des composés de formule (i), des compositions pharmaceutiques les comprenant et leur utilisation comme médicaments pour le traitement de maladies et d'infections causée par acinetobacter baumannii .
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15191743 | 2015-10-27 | ||
| PCT/EP2016/075499 WO2017072062A1 (fr) | 2015-10-27 | 2016-10-24 | Macrocycles peptidiques contre acinetobacter baumannii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43103B1 true MA43103B1 (fr) | 2020-08-31 |
Family
ID=54539821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA43103A MA43103B1 (fr) | 2015-10-27 | 2016-10-24 | Peptides macrocycliques contre acetinobacter baumannii |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR106511A1 (fr) |
| BR (1) | BR112018008585A2 (fr) |
| MA (1) | MA43103B1 (fr) |
-
2016
- 2016-10-24 BR BR112018008585A patent/BR112018008585A2/pt active Search and Examination
- 2016-10-24 MA MA43103A patent/MA43103B1/fr unknown
- 2016-10-27 AR ARP160103280A patent/AR106511A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR106511A1 (es) | 2018-01-24 |
| BR112018008585A2 (pt) | 2018-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39995B1 (fr) | Composés destinés à traiter l'amyotrophie spinale | |
| MX2022010520A (es) | Macrociclos peptidicos contra acinetobacter baumannii. | |
| MA40111A1 (fr) | Dérivés du tétrahydronaphtalène inhibant la protéine mcl-1 | |
| MX379459B (es) | Inhibidores de bromodominios. | |
| BR112015022643A2 (pt) | inibidores diidro-pirrolpiridinona | |
| PH12016500024A1 (en) | Bromodomain inhibitor | |
| NZ708593A (en) | Novel pyrazole derivative | |
| UA111588C2 (uk) | Композиція інгібітора jak для місцевого застосування | |
| BR112015022861A8 (pt) | inibidores de bromodomínio | |
| MA40225A (fr) | Composés dihydroisoquinolinone substitués | |
| UA113538C2 (xx) | Фторметил-5,6-дигідро-4h-$1,3]оксазини | |
| MA39165A1 (fr) | Dérivés de benzimidazole-proline pour leurs utilisations dans le traitement du syndrome des etats crepusculaires | |
| EA201591541A1 (ru) | Ингибиторы бета-секретазы 1 (bace 1) | |
| EA201590066A1 (ru) | Дифторгексагидроциклопентаоксазинилы и дифторгексагидробензоксазинилы в качестве ингибиторов бета-секретазы 1 | |
| MA43052B1 (fr) | Inhibiteurs de la kallicréine plasmatique humaine | |
| EA201492097A1 (ru) | 5-амино[1,4]тиазины в качестве ингибиторов бета-секретазы 1 | |
| EA201890532A1 (ru) | Новые аннелированные бензамиды | |
| JOP20190086A1 (ar) | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب | |
| EA201992090A1 (ru) | ДЕЙТЕРИРОВАННЫЕ СОЕДИНЕНИЯ ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА | |
| TN2018000214A1 (en) | Alkyl dihydroquinoline sulfonamide compounds | |
| MX2019004375A (es) | Inhibidores de bromodominios. | |
| MA39229A1 (fr) | Pyrrolidines, térahydrofuranes et cyclopentanes substitués utiles en tant qu'antagonistes des récepteurs des orexines | |
| MA38857B1 (fr) | Dérivés de 1-(pipérazin-1-yl)-2-([1,2,4]triazol-1-yl)-éthanone | |
| BR112015023078A2 (pt) | inibidores de pirrolopirimindina cdk9 quinase | |
| MX2019004187A (es) | Inhibidores de bromodominios. |